Teva Pharmaceutical Industries Ltd. — AGM Information 2005

Jun 19, 2005

C003	��� ������ ��������� ��"�		2
Public	TEVA- PHARMACEUTICAL INDUSTRIES LTD.
	2529	Corporation no: 520013954
	Stock Exchange/Market: ���
	310
	381	P.O.B 3190 , Petach Tikva 49131 , ,
	Tel: 03-9267297 , 03-9267281 Fax: 03-9267429
	E.mail address: DORIT@TEVA.CO.IL	Date of transmission: 19/06/2005
		Time of broadcast: 14:51 11:18:39
		Reference: 2005-02-043224

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000 The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	Following our announcement from June 16, regarding the agenda for Teva's annual shareholders meeting, please find attached the 6-K related thereto as filled in the US.

6-kAGMTEVA_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous name of reporting entity:
Date of revision of form structure: 18/04/2005
- - -
Name of the Signatory : Suesskind Dan Position of Signatory in the reporting corporation: Chief Financial Officer
Basel Telephone: 02-5892840 , Facsimile: 02-5892839 , E-mail: dan.suesskind@teva.co.il